Altria shares hit after National Cancer Institute director named acting head of the FDA

Indonesia Berita Berita

Altria shares hit after National Cancer Institute director named acting head of the FDA
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 72%

Altria investors don't seem to like the prospects for the cigarette maker under the new acting FDA commissioner.

div > div.group > p:first-child"> The company's stock fell to their lows of the day, trading around 0.3 percent lower, after National Cancer Institute Director Ned Sharpless was named interim head of the agency.

Sharpless' naming comes after Scott Gottlieb resigned last week from his post as FDA commissioner. Gottlieb called the use of e-cigarettes an"epidemic." He also threatened to pull all e-cigarette products if things did not improve.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

National Cancer Institute Director Ned Sharpless will be acting FDA commissionerNational Cancer Institute Director Ned Sharpless will be acting FDA commissionerNational Cancer Institute Director Ned Sharpless will serve as acting FDA Commissioner when Scott Gottlieb steps down from the agency next month, Health and Human Services Secretary Alex Azar said Tuesday.
Baca lebih lajut »

FDA approves first immunotherapy regimen for breast cancerFDA approves first immunotherapy regimen for breast cancerThe US Food and Drug Administration granted its first approval to an immunotherapy regimen for breast cancer, the agency announced Friday. The drug, Genentech's Tecentriq, was approved for use in combination with Abraxane chemotherapy for patients who have a type of advanced triple negative breast cancer.
Baca lebih lajut »

FDA Commissioner Gottlieb, who raised alarms about teen vaping, resignsFDA Commissioner Gottlieb, who raised alarms about teen vaping, resignsFDA Commissioner Scott Gottlieb, who raised national alarms about teenage vaping, is resigning
Baca lebih lajut »

Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Baca lebih lajut »

Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Baca lebih lajut »

FDA chief Gottlieb's departure might not actually be a good thing for vaping industryFDA chief Gottlieb's departure might not actually be a good thing for vaping industrySome have called FDA Commissioner Scott Gottlieb's resignation a boon for the e-cigarette industry. It may prove more complicated.
Baca lebih lajut »

FDA Commissioner Scott Gottlieb is resigningFDA Commissioner Scott Gottlieb is resigning
Baca lebih lajut »

Biotech shares continue to fall on FDA uncertaintyBiotech shares continue to fall on FDA uncertaintyThe biotech sector is on pace for its worst weekly decline since December, weighed down in part by uncertainty following this week's surprise announcement from FDA chief Scott Gottlieb that he will be stepping down next month.
Baca lebih lajut »

Biotech stocks fall after FDA chief Scott Gottlieb resignsBiotech stocks fall after FDA chief Scott Gottlieb resignsThe IBB, an ETF that tracks biotech's biggest players, was down more than 2 percent Wednesday, on pace for its worst day since February 7 when it lost 2.5 percent.
Baca lebih lajut »

FDA finds asbestos in three products sold by Claire'sFDA finds asbestos in three products sold by Claire'sThe FDA calls on Congress to modernize cosmetics safety rules after issuing an alert about asbestos contamination detected in three products sold by retailer Claire's
Baca lebih lajut »



Render Time: 2025-03-11 06:29:12